Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "LAR1:gu ;lar1:(lu)"

Sökning: LAR1:gu > Lunds universitet

  • Resultat 1-10 av 2403
Sortera/gruppera träfflistan
  • Aasa, Anna, et al. (författare)
  • Collecting dialect data and making use of them an interim report from Swedia 2000
  • 2000
  • Ingår i: Proceedings FONETIK 2000. - University of Gothenburg. ; s. 17-20
  • Konferensbidrag (övrigt vetenskapligt)abstract
    • This paper consists of two, somewhat disparate parts. In the first part, some experiences of two years of fieldwork are summarized, concentrating, as the subtitle suggests, on the very heart of phonetic fieldwork: the encounters and interviews with the informants. As a result of the fieldwork, the project now has access to recordings from approximately 1300<br /> speakers of more than 100 dialects of Swedish. We are currently initiating research on various aspects of the sound patterns of these dialects. The second part of the paper is meant to give an overview of some of our research plans for the near future.
  • Abendstein, Helmut, et al. (författare)
  • Quality of Life and Head and Neck Cancer: A 5 Year Prospective Study.
  • 2005
  • Ingår i: Laryngoscope. - Lippincott Williams & Wilkins. - 0023-852X. ; 115:12, s. 2183-2192
  • Tidskriftsartikel (refereegranskat)abstract
    • OBJECTIVES: Assessment of health-related quality of life (HRQL) in head and neck cancer patients from diagnosis to 5 years after start of treatment. STUDY DESIGN: A prospective, descriptive study METHODS: three hundred fifty-seven patients from Norway and Sweden filled in HRQL questionnaires, the European Organisation for Research and Treatment of Cancer (EORTC) QLQ-C30 and the EORTC QLQ-H and N35, six times during the first year and then after 5 years. At 5 years, 167 (87%) of the 192 living patients filled in questionnaires. RESULTS: Group data: clinical significant improvements in HRQL were not found between 1 and 5 years. Problems with teeth, opening of the mouth, dryness in the mouth, and sticky saliva were persistent or worsening. Similar findings were found regardless of sex, age, stage, or site when clinical significant changes are considered. Patients who died between 1 and 5 years reported reduced HRQL on 15 of 28 scales at 1 year compared with the survivors. Individual data: 40% of patients reported improved global HRQL from diagnosis to 5 years after start of treatment. In addition, 11% had "top scores" at both assessment points. The pattern in global HRQL scores also applies for most of the other function and symptom scales. CONCLUSION: After the first year after treatment, recovery of the persisting side effects of treatment cannot be expected for the group as a whole. Patients must be prepared for this. Some individual patients experience improvement in global HRQL. HRQL assessments in daily clinical practice can identify patients who are in need of additional support and symptom relief.
  • Aboul-Ata, Aboul-Ata E, et al. (författare)
  • Plant-Based Vaccines: Novel and Low-Cost Possible Route for Mediterranean Innovative Vaccination Strategies
  • 2014
  • Ingår i: Advances in Virus Research. - San Diego : Elsevier Academic Press Inc. - 0065-3527. ; 89, s. 1-37
  • Forskningsöversikt (refereegranskat)abstract
    • A plant bioreactor has enormous capability as a system that supports many biological activities, that is, production of plant bodies, virus-like particles (VLPs), and vaccines. Foreign gene expression is an efficient mechanism for getting protein vaccines against different human viral and nonviral diseases. Plants make it easy to deal with safe, inexpensive, and provide trouble-free storage. The broad spectrum of safe gene promoters is being used to avoid risk assessments. Engineered virus-based vectors have no side effect. The process can be manipulated as follows: (a) retrieve and select gene encoding, use an antigenic protein from GenBank and/or from a viral-genome sequence, (b) design and construct hybrid-virus vectors (viral vector with a gene of interest) eventually flanked by plant-specific genetic regulatory elements for constitutive expression for obtaining chimeric virus, (c) gene transformation and/or transfection, for transient expression, into a plant-host model, that is, tobacco, to get protocols processed positively, and then moving into edible host plants, (d) confirmation of protein expression by bioassay, PCR-associated tests (RT-PCR), Northern and Western blotting analysis, and serological assay (ELISA), (e) expression for adjuvant recombinant protein seeking better antigenicity, (f) extraction and purification of expressed protein for identification and dosing, (g) antigenicity capability evaluated using parental or oral delivery in animal models (mice and/or rabbit immunization), and (h) growing of construct-treated edible crops in protective green houses. Some successful cases of heterologous gene-expressed protein, as edible vaccine, are being discussed, that is, hepatitis C virus (HCV). R9 mimotope, also named hypervariable region 1 (HVR1), was derived from the HVR1 of HCV. It was used as a potential neutralizing epitope of HCV. The mimotope was expressed using cucumber mosaic virus coat protein (CP), alfalfa mosaic virus CP P3/RNA3, and tobacco mosaic virus (TMV) CP-tobacco mild green mosaic virus (TMGMV) CP as expression vectors into tobacco plants. Expressed recombinant protein has not only been confirmed as a therapeutic but also as a diagnostic tool. Herpes simplex virus 2 (HSV-2), HSV-2 gD, and HSV-2 VP16 subunits were transfected into tobacco plants, using TMV CP-TMGMV CP expression vectors.
  • Abraham-Nordling, Mirna, et al. (författare)
  • Incidence of Hyperthyroidism in Sweden.
  • 2011
  • Ingår i: European journal of endocrinology. - 1479-683X. ; 165, s. 899-905
  • Tidskriftsartikel (refereegranskat)abstract
    • Introduction: The incidence of hyperthyroidism has been reported in various countries to be 23-93/100000 inhabitants per year. This extended study has evaluated the incidence for similar to 40% of the Swedish population of 9 million inhabitants. Sweden is considered to be iodine sufficient country. Methods:All patients including children, who were newly diagnosed with overt hyperthyroidism in the years 2003-2005, were prospectively registered in a multicenter study. The inclusion criteria are as follows:clinical symptoms and/or signs of hyperthyroidism with plasma TSH concentration below 0.2 mIE/l and increased plasma levels of free/total triiodothyronine and/or free/total thyroxine. Patients with relapse of hyperthyroidism or thyroiditis were not included. The diagnosis of Graves&#39; disease (GD), toxic multinodular goiter (TMNG) and solitary toxic adenoma (STA), smoking, initial treatment, occurrence of thyroid-associated eye symptoms/signs, and demographic data were registered. Results:A total of 2916 patients were diagnosed with de novo hyperthyroidism showing the total incidence of 27.6/100 000 inhabitants per year. The incidence of GD was 21.0/100 000 and toxic nodular goiter (TNG=STA+TMNG) occurred in 692 patients, corresponding to an annual incidence of 6.5/100 000. The incidence was higher in women compared with men (4.2:1). Seventy-five percent of the patients were diagnosed with GD, in whom thyroid-associated eye symptoms/signs occurred during diagnosis in every fifth patient. Geographical differences were observed. Conclusion:The incidence of hyperthyroidism in Sweden is in a lower range compared with international reports. Seventy-five percent of patients with hyperthyroidism had GD and 20% of them had thyroid-associated eye symptoms/signs during diagnosis. The observed geographical differences require further studies.
  • Abraham-Nordling, Mirna, et al. (författare)
  • Thyroid-associated ophthalmopathy; quality of life follow-up of patients randomized to treatment with antithyroid drugs or radioiodine.
  • 2010
  • Ingår i: European journal of endocrinology / European Federation of Endocrine Societies. - 1479-683X. ; 163:4, s. 651-7
  • Tidskriftsartikel (refereegranskat)abstract
    • Objective: The objective of this study was to investigate quality of life (QoL) in patients with Graves&#39; disease treated with radioiodine or antithyroid drugs. Design and methods: The design of the study consists of an open, prospective, randomized multicenter trial between radioiodine and medical treatment. A total of 308 patients were included in the study group: 145 patients in the medical group and 163 patients in the radioiodine group. QoL was measured with a 36-item Short Form Health Status Survey questionnaire (SF-36) at six time points during the 48-month study period. Results: Patient who developed or got worse of thyroid-associated ophthalmopathy (TAO) at any time point during the 4-year study period (TAO group) had lower QoL when no respect was paid to the mode of treatment. TAO occurred in 75 patients who had radioiodine treatment at some time point during the study period as compared with TAO in 40 medically treated patients (P&lt;0.0009). Comparisons between the group of patients who have had TAO versus the group without TAO, in relation to treatments and time, showed significantly decreased QoL scores for the TAO groups at several time points during the study. In patients without TAO, there were no differences in QoL related to mode of treatment. Conclusions: The QoL in patients with Graves&#39; ophthalmopathy was similar in radioiodine and medically treated patients, but patients who developed or had worsening of TAO had decreased QoL independent of mode of treatment. Furthermore, patients with TAO recovered physically within 1 year but it took twice as long for them to recover mentally.
  • Abrahamsson, Jonas, et al. (författare)
  • Improved outcome after relapse in children with acute myeloid leukaemia.
  • 2007
  • Ingår i: British journal of haematology. - 0007-1048. ; 136:2, s. 229-236
  • Tidskriftsartikel (refereegranskat)abstract
    • In the Nordic Society for Paediatric Haematology and Oncology paediatric study acute myeloid leukaemia (AML) 93, event-free survival was 50% and overall survival was 66%, indicating that many patients were cured following relapse. Factors influencing outcome in children with relapsed AML were investigated. The study included all 146 children in the Nordic countries diagnosed with AML between 1988 and 2003, who relapsed. Data on disease characteristics and relapse treatment were related to outcome. Sixty-six percentage achieved remission with survival after relapse (5 years) 34 +/- 4%. Of 122 patients who received re-induction therapy, 77% entered remission with 40 +/- 5% survival. Remission rates were similar for different re-induction regimens but fludarabine, cytarabine, granulocyte colony-stimulating factor-based therapy had low treatment-related mortality. Prognostic factors for survival were duration of first complete remission (CR1) and stem cell transplantation (SCT) in CR1. In early relapse (&lt; 1 year in CR1), survival was 21 +/- 5% compared with 48 +/- 6% in late relapse. For children receiving re-induction therapy, survival in early relapse was 29 +/- 6% and 51 +/- 6% in late. Patients treated in CR1 with SCT, autologous SCT or chemotherapy had a survival of 18 +/- 9, 5 +/- 5 and 41 +/- 5%, respectively. Survival was 62 +/- 6% in 64 children given SCT as part of their relapse therapy. A significant proportion of children with relapsed AML can be cured, even those with early relapse. Children who receive re-induction therapy, enter remission and proceed to SCT can achieve a cure rate of 60%.
  • Abrahamsson, Jonas, et al. (författare)
  • Response-guided induction therapy in pediatric acute myeloid leukemia with excellent remission rate.
  • 2011
  • Ingår i: Journal of clinical oncology : official journal of the American Society of Clinical Oncology. - 1527-7755. ; 29:3, s. 310-5
  • Tidskriftsartikel (refereegranskat)abstract
    • PURPOSE To evaluate the early treatment response in children with acute myeloid leukemia (AML) using a response-guided induction strategy that includes idarubicin in the first course. PATIENTS AND METHODS All Nordic children with AML younger than 15 years (n = 151) were treated on the Nordic Society for Pediatric Hematology and Oncology (NOPHO) AML 2004 protocol. After the first course of idarubicin, cytarabine, etoposide, and 6-thioguanin, patients with good response were allowed hematologic recovery before the second course, whereas patients with a poor (≥ 15% blasts) or intermediate (5% to 14.9% blasts) were recommended to proceed immediately with therapy. Patients not in remission after the second course received fludarabine, cytarabine, and granulocyte colony-stimulating factor. Poor responders received allogeneic stem-cell transplantation (SCT) as consolidation. Results Seventy-four percent of patients had good response, 17% had intermediate response, and 7% had poor response after the first course. The overall remission frequency was 97.4%, with 92% in remission after the second course. The rate of induction death was 1.3%. Patients with an intermediate response had a lower event-free survival of 35% compared with good (61%) and poor responders (82%). CONCLUSION The NOPHO-AML 2004 induction strategy gives an excellent remission rate with low toxic mortality in an unselected population. Outcome is worse in patients with intermediate response but may be improved by intensifying consolidation in this group using SCT.
  • Abrahamsson, Maria, et al. (författare)
  • Steric influence on the excited-state lifetimes of ruthenium complexes with bipyridyl-alkanylene-pyridyl ligands.
  • 2008
  • Ingår i: Inorganic Chemistry. - ACS. - 0020-1669. ; 47:9, s. 3540-3548
  • Tidskriftsartikel (refereegranskat)abstract
    • The structural effect on the metal-to-ligand charge transfer (MLCT) excited-state lifetime has been investigated in bis-tridentate Ru(II)-polypyridyl complexes based on the terpyridine-like ligands [6-(2,2'-bipyridyl)](2-pyridyl)methane (1) and 2-[6-(2,2'-bipyridyl)]-2-(2-pyridyl)propane (2). A homoleptic ([Ru(2)(2)](2+)) and a heteroleptic complex ([Ru(ttpy)(2)](2+)) based on the new ligand 2 have been prepared and their photophysical and structural properties studied experimentally and theoretically and compared to the results for the previously reported [Ru(1)(2)](2+). The excited-state lifetime of the homoleptic Ru-II complex with the isopropylene-bridged ligand 2 was found to be 50 times shorter than that of the corresponding homoleptic Ru-II complex of ligand 1, containing a methylene bridge. A comparison of the ground-state geometries of the two homoleptic complexes shows that steric interactions involving the isopropylene bridges make the coordination to the central Ru-II ion less octahedral in [Ru(2)(2)](2+) than in [Ru(1)(2))(2+). Calculations indicate that the structural differences in these complexes influence their ligand field splittings as well as the relative stabilities of the triplet metal-to-ligand charge transfer ((MLCT)-M-3) and metal-centered ((MC)-M-3) excited states. The large difference in measured excited-state lifetimes for the two homoleptic Ru-II complexes is attributed to a strong influence of steric interactions on the ligand field strength, which in turn affects the activation barriers for thermal conversion from (MLCT)-M-3 states to short-lived (MC)-M-3 states.
  • Abramo, Antonio, et al. (författare)
  • Osteotomy of distal radius fracture malunion using a fast remodeling bone substitute consisting of calcium sulphate and calcium phosphate.
  • 2010
  • Ingår i: Journal of Biomedical Materials Research. Part B - Applied Biomaterials. - 1552-4981 .- 1552-4973. ; 92B, s. 281-286
  • Tidskriftsartikel (refereegranskat)abstract
    • Malunion after a distal radius fracture can be treated with an osteotomy of the distal radius. Autologous iliac crest bone graft is often used to fill the gap, but the procedure is associated with donor site morbidity. In this study a novel fast resorbing biphasic bone substitute consisting of a mixture of calcium sulphate and calcium phosphate is used (Cerament BoneSupport AB, Sweden). Fifteen consecutive patients, with a mean age of 52 (27-71) years were included. All had a malunion after a distal radius fracture and underwent an osteotomy. A fragment specific fixation system, TriMed(R) (TriMed, Valencia, CA), consisting of a Buttress Pin(R) and a Radial Pin Plate(R) were used for fixation and a calcium sulphate and calcium phosphate mixture as bone substitute. The patients were followed for 1 year. Grip strength increased from 61 (28-93)% of the contralateral hand to 85 (58-109)%, p &lt; 0.001. DASH scores decreased from 37 (22-61) to 24 (2-49) p = 0.003. Radiographically all osteotomies healed. An increase of ulnar variance was noted during healing from 1.8 mm immediately postoperatively to 2.6 mm at final follow up. Osteotomy can increase grip strength and decease disability after a malunited fracture. In the present series the bone substitute was replaced by bone, but a minor loss of the achieved radiographic correction was noted in some patients during osteotomy healing. A more rigid fixation may improve the radiographic outcome with this kind of bone substitute. (c) 2009 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 2010.
Skapa referenser, mejla, bekava och länka
  • Resultat 1-10 av 2403
fritt online (701)
Typ av publikation
tidskriftsartikel (2228)
rapport (31)
bokkapitel (31)
konferensbidrag (28)
samlingsverk (redaktörskap) (27)
bok (24)
visa fler...
forskningsöversikt (19)
recension (8)
doktorsavhandling (7)
visa färre...
Typ av innehåll
refereegranskat (2236)
övrigt vetenskapligt (154)
populärvet., debatt m.m. (13)
Blennow, Kaj (103)
Minthon, Lennart (95)
Zetterberg, Henrik (89)
Ohlsson, Claes (84)
Hansson, Oskar (73)
Karlsson, Magnus, (71)
visa fler...
Anckarsäter, Henrik (67)
Ljunggren, Östen, (59)
Råstam, Maria (53)
Mellström, Dan (51)
Mellstrom, Dan (49)
Ljunggren, Osten (47)
Gillberg, Christophe ... (43)
Lindblad, Ulf, (41)
Lorentzon, Mattias, (39)
Khaw, Kay-Tee (35)
Corvellec, Hervé (35)
Groop, Leif (34)
Pendrill, Ann-Marie (34)
Hofman, Albert, (32)
Mellström, Dan, 1945 ... (32)
Vandenput, Liesbeth (32)
Lilja, Hans (30)
Londos, Elisabet (30)
Melander, Olle (30)
Nilsson, Peter (30)
Källén, Karin (30)
Allwood, Carl Martin (29)
Wallin, Anders (28)
Hugosson, Jonas (26)
Boeing, Heiner (25)
Anckarsater, H (25)
Ohlsson, C (24)
Barregard, Lars (24)
Harris, Tamara B. (24)
Nilsson, Thomas (23)
Mellstrom, D. (23)
Dahlin-Ivanoff, Synn ... (23)
Oden, A (22)
Gudnason, Vilmundur, (22)
Rivadeneira, Fernand ... (22)
Mattsson, Niklas, (22)
Johansson, H (21)
Tumino, Rosario (20)
Uitterlinden, Andre ... (20)
Odén, Anders, 1942-, (20)
Barregård, Lars, 194 ... (20)
Svensson, Johan, (20)
Andreasen, Niels (20)
Andreasson, Ulf (20)
visa färre...
Göteborgs universitet (2403)
Karolinska Institutet (539)
Uppsala universitet (340)
Umeå universitet (237)
Linköpings universitet (195)
visa fler...
Chalmers tekniska högskola (141)
Högskolan i Borås (37)
Stockholms universitet (33)
Linnéuniversitetet (31)
Sveriges Lantbruksuniversitet (30)
Örebro universitet (29)
Högskolan i Halmstad (27)
Malmö högskola (27)
Kungliga Tekniska Högskolan (26)
Högskolan i Jönköping (21)
Högskolan Kristianstad (18)
Högskolan i Skövde (13)
Högskolan Dalarna (12)
Mittuniversitetet (10)
Karlstads universitet (7)
Ersta Sköndal högskola (6)
Mälardalens högskola (6)
Luleå tekniska universitet (5)
Sophiahemmet Högskola (5)
Högskolan i Gävle (4)
RISE (3)
Högskolan Väst (2)
Södertörns högskola (1)
Blekinge Tekniska Högskola (1)
visa färre...
Engelska (2287)
Svenska (110)
Tyska (4)
Franska (1)
Spanska (1)
Forskningsämne (UKÄ/SCB)
Medicin och hälsovetenskap (1785)
Naturvetenskap (421)
Samhällsvetenskap (394)
Humaniora (105)
Teknik (83)
Lantbruksvetenskap (34)


pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy